BELINDA SCOTT: Open Payments
NPI 1043610413 · YPSILANTI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 22 payments from 7 companies in 2025. Trend: 2023 $889 · 2024 $668 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $182 |
| Neurocrine BioSciences, Inc. | 5 | $122 |
| Alkermes, Inc. | 4 | $95 |
| ABBVIE INC. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: INGREZZA, REXULTI, ARISTADA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, VRAYLAR, Auvelity, CAPLYTA.
Industry payments across MI — which companies pay providers there.
